The pharma company had posted strong fourth quarter profits but margins had contracted. The R&D spend for the quarter stood at 9 percent, says Yogesh M Agrawal, Managing Director of the company.
first published: Apr 29, 2016 03:35 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
